LEAP THERAPEUTICS, INC. Quarterly Current Ratio in % from Q3 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Leap Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2017 to Q3 2024.
  • Leap Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 495 %, a 37% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 495 -291 -37% Sep 30, 2024
Q2 2024 581 -189 -24.5% Jun 30, 2024
Q1 2024 661 -129 -16.4% Mar 31, 2024
Q4 2023 769 -79.8 -9.4% Dec 31, 2023
Q3 2023 786 -213 -21.4% Sep 30, 2023
Q2 2023 770 -357 -31.7% Jun 30, 2023
Q1 2023 790 -255 -24.4% Mar 31, 2023
Q4 2022 848 -28.6 -3.26% Dec 31, 2022
Q3 2022 999 +244 +32.4% Sep 30, 2022
Q2 2022 1.13K +482 +74.7% Jun 30, 2022
Q1 2022 1.04K +269 +34.6% Mar 31, 2022
Q4 2021 877 +206 +30.8% Dec 31, 2021
Q3 2021 755 +262 +53.2% Sep 30, 2021
Q2 2021 645 +317 +96.5% Jun 30, 2021
Q1 2021 776 +606 +356% Mar 31, 2021
Q4 2020 670 +505 +305% Dec 31, 2020
Q3 2020 493 +274 +125% Sep 30, 2020
Q2 2020 328 +49.6 +17.8% Jun 30, 2020
Q1 2020 170 -191 -52.8% Mar 31, 2020
Q4 2019 166 -287 -63.4% Dec 31, 2019
Q3 2019 219 -284 -56.5% Sep 30, 2019
Q2 2019 279 -193 -40.9% Jun 30, 2019
Q1 2019 361 -94.3 -20.7% Mar 31, 2019
Q4 2018 453 +15.5 +3.55% Dec 31, 2018
Q3 2018 503 +369 +275% Sep 30, 2018
Q2 2018 471 Jun 30, 2018
Q1 2018 455 Mar 31, 2018
Q4 2017 438 Dec 31, 2017
Q3 2017 134 Sep 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.